Skip to content
Search

Latest Stories

Patients risk access to care, medicines due to pharmacist workforce crisis

The ongoing pharmacist workforce crisis has posed a significant risk to patients’ access to care, medicines and advice -- particularly affecting the elderly and vulnerable living in areas with health inequalities.

Many from the sector have raised concerns about this issue with the Company Chemists’ Association (CCA) recently acknowledging the shortage of pharmacists or pharmacy technicians in the country to meet the needs of patients and the NHS.


The trade body representing almost 50 per cent of the community pharmacy sector said that pharmacy teams are exhausted after working tirelessly during the pandemic, adding that Covid, Brexit and NHS reforms have exacerbated the shortage.

Covid and winter-related sickness absences are adding to the strain and with Brexit it has become difficult to attract overseas pharmacists to the UK.

Malcolm Harrison Hi Res website Malcolm Harrison, CEO, Company Chemists’ Association

Malcolm Harrison, CEO of the CCA said: “The government needs to acknowledge the acute workforce crisis that community pharmacy is facing and urgently take action for all parts of primary care.”

The association noted that the government has been slow in responding to the shortage as “workforce crisis was confirmed earlier this year when pharmacists entered the Home Office’s Shortage Occupation List.”

The NHS plans to recruit a total of 6,000 pharmacists in England by 2024, equivalent to nearly three full years of new pharmacists, with no concrete plans to actively encourage students to take up additional places at universities, it said.

Harrison said: “The pressures facing the pharmacist workforce, and the creation of new positions in the NHS, when insufficient additional pharmacists are being trained, is a significant threat to healthcare in England. Fundamentally, without action patient access to medicines is likely to suffer.”

CCA noted that in recent months many pharmacies have been unable to find a pharmacist during times of higher demand, escalating employment costs which is impacting viability of pharmacies.

Closure of pharmacies, both temporary and permanent, will become unavoidable if the situation does not improve in future.

Leyla Hannbeck, chief executive, Association of Independent Multiple Pharmacies (AIMp) said: “The NHS’s primary care networks – GPs and clinics – have been told by NHS England to recruit 6,000 pharmacists by 2024 and that this cost will be funded by the NHS, creating an un-even playing field that pharmacies who are in year 5 of a 7 year funding cut cannot compete with.”

Most of these recruits are expected to come from already stretched community pharmacies and hospitals.

Calling it a bizarre step Hannbeck said: “The move to entice pharmacists away comes just at the point the NHS is encouraging community pharmacies to help alleviate the pressures on GPs by offering additional services.”

She informed that the NHSE will hold a meeting with pharmacy bodies in early December to discuss the issues and hopefully find a solution.

Community pharmacies have worked hard during the pandemic to provide care and service to local communities and now onus is on the government to “seriously reconsider its current healthcare plans” to ensure patients’ access to professional advice, medicines, and care at local pharmacies, CCA said.

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less